<DOC>
	<DOCNO>NCT00807339</DOCNO>
	<brief_summary>This dose escalation study use CyberKnife radiotherapy device small surgical medically untreatable renal tumor . Patients renal tumor 5cms less diameter accrue onto study . The ability CyberKnife ablate renal tumor maintain renal function dose escalation assess .</brief_summary>
	<brief_title>CyberKnife Unresectable Renal Tumors</brief_title>
	<detailed_description>The CyberKnife Robotic Radiosurgery System unique radiosurgical system capable treating tumor anywhere body noninvasively sub-millimeter accuracy . The CyberKnife System deliver radiation use precise target methodology allow focal treatment margin around target , thus limit volume adjacent tissue receive high dos radiation . This turn allow delivery high dos radiation prostate short series treatment .</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Tumor size 5 cm less Radiographic evidence malignancy Histologically verify primary renal malignancy . If kidney biopsy inconclusive radiologist determines tumor base CT/MRI highly suspicious cancer , may participate Patients highly suspicious lesion CT MRI One three gold fiducials place around tumor Contradiction patient refusal partial complete nephrectomy Age 18 great KPS score 70 great Irreversible coagulopathies preclude fiducial placement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>CyberKnife</keyword>
</DOC>